Statement of Organization, Functions, and Delegations of Authority, 35651-35652 [2015-15237]
Download as PDF
<![CDATA[
tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 119 / Monday, June 22, 2015 / Notices
Insurance Marketplace, and
‘‘Marketplace’’). In order to effectively
implement and administer these
changes, we must provide information
to consumers, providers, and other
stakeholders through education and
outreach programs regarding how
existing programs will change and the
expanded range of health coverage
options available, including private
health insurance coverage through the
Marketplace. The APOE (the Panel)
allows us to consider a broad range of
views and information from interested
audiences in connection with this effort
and to identify opportunities to enhance
the effectiveness of education strategies
concerning the Affordable Care Act.
The scope of this panel also includes
advising on issues pertaining to the
education of providers and stakeholders
with respect to the Affordable Care Act
and certain provisions of the Health
Information Technology for Economic
and Clinical Health (HITECH) Act
enacted as part of the American
Recovery and Reinvestment Act of 2009
(ARRA).
On January 21, 2011, the Panel’s
charter was renewed and the Panel was
renamed the Advisory Panel for
Outreach and Education. The Panel’s
charter was most recently renewed on
January 21, 2015, and will terminate on
January 21, 2017 unless renewed by
appropriate action.
Under the current charter, the APOE
will advise the Secretary and the
Administrator on optimal strategies for
the following:
• Developing and implementing
education and outreach programs for
individuals enrolled in, or eligible for,
Medicare, Medicaid, and the Children’s
Health Insurance Program (CHIP), or
coverage available through the Health
Insurance Marketplace.
• Enhancing the federal government’s
effectiveness in informing Health
Insurance Marketplace, Medicare,
Medicaid, and CHIP consumers, issuers,
providers, and stakeholders, through
education and outreach programs, on
issues regarding these programs,
including the appropriate use of publicprivate partnerships to leverage the
resources of the private sector in
educating beneficiaries, providers, and
stakeholders.
• Expanding outreach to vulnerable
and underserved communities,
including racial and ethnic minorities,
in the context of Health Insurance
Marketplace, Medicare, Medicaid, and
CHIP education programs.
• Assembling and sharing an
information base of ‘‘best practices’’ for
helping consumers evaluate health
coverage options.
VerDate Sep<11>2014
17:45 Jun 19, 2015
Jkt 235001
• Building and leveraging existing
community infrastructures for
information, counseling, and assistance.
• Drawing the program link between
outreach and education, promoting
consumer understanding of health care
coverage choices, and facilitating
consumer selection/enrollment, which
in turn support the overarching goal of
improved access to quality care,
including prevention services,
envisioned under the Affordable Care
Act.
The current members of the Panel are:
Samantha Artiga, Principal Policy
Analyst, Kaiser Family Foundation;
Joseph Baker, President, Medicare
Rights Center; Kellan Baker, Senior
Fellow, Center for American Progress;
Philip Bergquist, Manager, Health
Center Operations, Children’s Health
Insurance Program Reauthorization Act
(CHIPRA) Outreach & Enrollment
Project and Director, Michigan Primary
Care Association; Marjorie Cadogan,
Executive Deputy Commissioner,
Department of Social Services; Barbara
Ferrer, Chief Strategy Officer, W. K.
Kellogg Foundation; Shelby Gonzales,
Senior Health Outreach Associate,
Center on Budget & Policy Priorities; Jan
Henning, Benefits Counseling & Special
Projects Coordinator, North Central
Texas Council of Governments’ Area
Agency on Aging; Louise Knight,
Director, The Sidney Kimmel
Comprehensive Cancer Center at Johns
Hopkins; Miriam Mobley-Smith, Dean,
Chicago State University, College of
Pharmacy; Ana Natale-Pereira, M.D.,
Associate Professor of Medicine,
Rutgers-New Jersey Medical School;
Roanne Osborne-Gaskin, M.D.,
Associate Medical Director,
Neighborhood Health Plan of Rhode
Island; Megan Padden, Vice President,
Sentara Health Plans; Jeanne Ryer,
Director, New Hampshire Citizens
Health Initiative, University of New
Hampshire; Carla Smith, Executive Vice
President, Healthcare Information and
Management Systems Society (HIMSS);
Winston Wong, Medical Director,
Community Benefit Director, Kaiser
Permanente and Darlene Yee-Melichar,
Professor & Coordinator, San Francisco
State University.
II. Provisions of This Notice
In the May 29, 2015 Federal Register
(80 FR 30684), in accordance with
section 10(a) of the FACA, we published
a notice announcing a June 25, 2015
meeting of the APOE. In this notice, we
are notifying interested parties we are
rescheduling the meeting to July 22,
2015. The agenda for the July 22, 2015
meeting will include the following:
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
35651
• Welcome and listening session with
CMS leadership
• Recap of the previous (March 19,
2015) meeting
• Affordable Care Act initiatives
• An opportunity for public comment
• Meeting summary, review of
recommendations, and next steps
Individuals or organizations that wish
to make a 5-minute oral presentation on
an agenda topic should submit a written
copy of the oral presentation to the DFO
at the address listed in the ADDRESSES
section of this notice by the date listed
in the DATES section of this notice. The
number of oral presentations may be
limited by the time available.
Individuals not wishing to make an oral
presentation may submit written
comments to the DFO at the address
listed in the ADDRESSES section of this
notice by the date listed in the DATES
section of this notice.
Authority: Sec. 222 of the Public Health
Service Act (42 U.S.C. 217a) and sec. 10(a)
of Pub. L. 92–463 (5 U.S.C. App. 2, sec. 10(a)
and 41 CFR 102–3).
Dated: June 16, 2015.
Andrew M. Slavitt,
Acting Administrator Centers for Medicare
& Medicaid Services.
[FR Doc. 2015–15263 Filed 6–17–15; 4:15 pm]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Statement of Organization, Functions,
and Delegations of Authority
Office of Legislative Affairs and
Budget, Administration for Children
and Families, HHS.
ACTION: Notice.
AGENCY:
Statement of Organizations,
Functions, and Delegations of
Authority. The Administration for
Children and Families (ACF) has
realigned the Office of Legislative
Affairs and Budget (OLAB). This
realignment will permit the office to
serve as the ACF liaison to the
Government Accountability Office
(GAO) and to the Office of Inspector
General (OIG) for OIG engagements
relating to the management of ACF
programs.
FOR FURTHER INFORMATION CONTACT:
Matthew McKearn, Office of Legislative
Affairs and Budget, 901 D Street SW.,
Washington, DC 20447, 202–401–9222.
This notice amends Part K of the
Statement of Organization, Functions,
and Delegations of Authority of the
SUMMARY:
E:\FR\FM\22JNN1.SGM
22JNN1
tkelley on DSK3SPTVN1PROD with NOTICES
35652
Federal Register / Vol. 80, No. 119 / Monday, June 22, 2015 / Notices
Department of Health and Human
Services, Administration for Children
and Families (ACF), as follows: Chapter
KT, as last amended, 65 FR 30413–14,
May 11, 2000.
I. Under Chapter KT, Office of
Legislative Affairs and Budget, delete
KT.00 Mission in its entirety and
replace with the following:
KT.00 MISSION. The Office of
Legislative Affairs and Budget (OLAB)
provides leadership in the development
of legislation, budget, and policy,
ensuring consistency in these areas
among ACF program and staff offices,
and with ACF and the Department’s
vision and goals. It advises the Assistant
Secretary for Children and Families on
all policy and programmatic matters
that substantially impact the agency’s
legislative program, budget
development, budget execution, and
regulatory agenda. The Office serves as
the primary contact for the Department,
the Executive Branch, and the Congress
on all legislative, budget development
and execution, and regulatory activities.
The Office serves as the ACF liaison to
the Government Accountability Office
and to the Office of Inspector General
(OIG) for OIG engagements relating to
the management of ACF programs.
II. Under Chapter KT, Office of
Legislative Affairs and Budget, delete
KT.20, Functions, Paragraph B, in its
entirety and replace with the following:
B. The Division of Legislative and
Regulatory Affairs serves as the focal
point for congressional liaison in ACF;
provides guidance to the Assistant
Secretary for Children and Families and
senior ACF staff on congressional
activities and relations; manages the
preparation of testimony and briefings
for programmatic and budget-related
hearings; negotiates clearance of
testimony; monitors hearings and other
congressional activities that affect ACF
programs; and responds to
congressional inquiries.
The Division manages the ACF
legislative planning cycle and the
development of Reports to Congress;
reviews and analyzes a wide range of
congressional policy documents
including: legislative proposals,
pending legislation, and bill reports;
solicits and synthesizes internal ACF
comments on such documents;
negotiates legislative policy positions
with the Department and the Executive
Branch; and reviews other policy
significant documents to ensure
consistency with statutory and
congressional intent and the agency
legislative agenda.
The Division manages the ACF
regulatory development process;
VerDate Sep<11>2014
17:45 Jun 19, 2015
Jkt 235001
negotiates regulatory policy positions
with the Department and the Executive
Branch; and provides guidance to ACF
program and staff components on policy
and programmatic matters related to the
regulatory development process.
The Division manages all Government
Accountability Office (GAO)
engagements with ACF; coordinates
entrance and exit conferences within
ACF; ensures GAO requests for
information are fulfilled; and
coordinates ACF comments on GAO
draft reports and Statements of Action
on GAO’s recommendations.
The Division facilitates OIG
engagements relating to the management
of ACF programs, to include, but not be
limited to, audits to determine whether
an ACF program office met its statutory
requirements; audits to determine
whether an ACF program office
complied with internal policies and
procedures; evaluations of an ACF
program for efficiency and effectiveness;
and evaluation of both ACF
management and selected grantees’
management of their grants.
III. Continuation of Policy. Except as
inconsistent with this realignment, all
statements of policy and interpretations
with respect to organizational
components affected by this notice
within ACF, heretofore issued and in
effect on this date of this realignment
are continued in full force and effect.
IV. Delegation of Authority. All
delegations and redelegations of
authority made to officials and
employees of affected organizational
components will continue in them or
their successors pending further
redelegations, provided they are
consistent with this realignment.
V. Funds, Personnel, and Equipment.
Transfer of organizations and functions
affected by this realignment shall be
accompanied in each instance by direct
and support funds, positions, personnel,
records, equipment, supplies, and other
resources.
This realignment will be effective
upon date of signature.
Dated: June 12, 2015.
Mark H. Greenberg,
Acting Assistant Secretary for Children and
Families.
[FR Doc. 2015–15237 Filed 6–19–15; 8:45 am]
BILLING CODE 4184–34–P
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2015–N–0097]
Mirwaiss Aminzada: Debarment Order
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is issuing an
order under the Federal Food, Drug, and
Cosmetic Act (the FD&C Act)
permanently debarring Mirwaiss
Aminzada from providing services in
any capacity to a person that has an
approved or pending drug product
application. FDA bases this order on a
finding that Mr. Aminzada was
convicted of a felony under Federal law
for conduct relating to the regulation of
a drug product. Mr. Aminzada was
given notice of the proposed permanent
debarment and an opportunity to
request a hearing within the timeframe
prescribed by regulation. Mr. Aminzada
failed to request a hearing. Mr.
Aminzada’s failure to request a hearing
constitutes a waiver of his right to a
hearing concerning this action.
DATES: This order is effective June 22,
2015.
SUMMARY:
Submit applications for
termination of debarment to the
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, Rm. 1061, Rockville,
MD 20852.
FOR FURTHER INFORMATION CONTACT:
Kenny Shade (ELEM–4144), Office of
Regulatory Affairs, Food and Drug
Administration, 12420 Parklawn Drive,
Rockville, MD 20857, 301–796–4640.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
I. Background
Section 306(a)(2)(B) of the FD&C Act
(21 U.S.C. 335a(a)(2)(B)) requires
debarment of an individual if FDA finds
that the individual has been convicted
of a felony under Federal law for
conduct relating to the regulation of any
drug product under the FD&C Act.
On June 10, 2014, the U.S. District
Court for the Eastern District of Virginia
entered judgment against Mr. Aminzada
for one count of introducing misbranded
drugs into interstate commerce with
intent to defraud or mislead, in
violation of sections 301(a) and
303(a)(2) of the FD&C Act (21 U.S.C.
331(a) and 333(a)(2)).
FDA’s finding that debarment is
appropriate is based on the felony
conviction referenced herein. The
E:\FR\FM\22JNN1.SGM
22JNN1
]]>Agencies
[Federal Register Volume 80, Number 119 (Monday, June 22, 2015)]
[Notices]
[Pages 35651-35652]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-15237]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Statement of Organization, Functions, and Delegations of
Authority
AGENCY: Office of Legislative Affairs and Budget, Administration for
Children and Families, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Statement of Organizations, Functions, and Delegations of
Authority. The Administration for Children and Families (ACF) has
realigned the Office of Legislative Affairs and Budget (OLAB). This
realignment will permit the office to serve as the ACF liaison to the
Government Accountability Office (GAO) and to the Office of Inspector
General (OIG) for OIG engagements relating to the management of ACF
programs.
FOR FURTHER INFORMATION CONTACT: Matthew McKearn, Office of Legislative
Affairs and Budget, 901 D Street SW., Washington, DC 20447, 202-401-
9222.
This notice amends Part K of the Statement of Organization,
Functions, and Delegations of Authority of the
[[Page 35652]]
Department of Health and Human Services, Administration for Children
and Families (ACF), as follows: Chapter KT, as last amended, 65 FR
30413-14, May 11, 2000.
I. Under Chapter KT, Office of Legislative Affairs and Budget,
delete KT.00 Mission in its entirety and replace with the following:
KT.00 MISSION. The Office of Legislative Affairs and Budget (OLAB)
provides leadership in the development of legislation, budget, and
policy, ensuring consistency in these areas among ACF program and staff
offices, and with ACF and the Department's vision and goals. It advises
the Assistant Secretary for Children and Families on all policy and
programmatic matters that substantially impact the agency's legislative
program, budget development, budget execution, and regulatory agenda.
The Office serves as the primary contact for the Department, the
Executive Branch, and the Congress on all legislative, budget
development and execution, and regulatory activities. The Office serves
as the ACF liaison to the Government Accountability Office and to the
Office of Inspector General (OIG) for OIG engagements relating to the
management of ACF programs.
II. Under Chapter KT, Office of Legislative Affairs and Budget,
delete KT.20, Functions, Paragraph B, in its entirety and replace with
the following:
B. The Division of Legislative and Regulatory Affairs serves as the
focal point for congressional liaison in ACF; provides guidance to the
Assistant Secretary for Children and Families and senior ACF staff on
congressional activities and relations; manages the preparation of
testimony and briefings for programmatic and budget-related hearings;
negotiates clearance of testimony; monitors hearings and other
congressional activities that affect ACF programs; and responds to
congressional inquiries.
The Division manages the ACF legislative planning cycle and the
development of Reports to Congress; reviews and analyzes a wide range
of congressional policy documents including: legislative proposals,
pending legislation, and bill reports; solicits and synthesizes
internal ACF comments on such documents; negotiates legislative policy
positions with the Department and the Executive Branch; and reviews
other policy significant documents to ensure consistency with statutory
and congressional intent and the agency legislative agenda.
The Division manages the ACF regulatory development process;
negotiates regulatory policy positions with the Department and the
Executive Branch; and provides guidance to ACF program and staff
components on policy and programmatic matters related to the regulatory
development process.
The Division manages all Government Accountability Office (GAO)
engagements with ACF; coordinates entrance and exit conferences within
ACF; ensures GAO requests for information are fulfilled; and
coordinates ACF comments on GAO draft reports and Statements of Action
on GAO's recommendations.
The Division facilitates OIG engagements relating to the management
of ACF programs, to include, but not be limited to, audits to determine
whether an ACF program office met its statutory requirements; audits to
determine whether an ACF program office complied with internal policies
and procedures; evaluations of an ACF program for efficiency and
effectiveness; and evaluation of both ACF management and selected
grantees' management of their grants.
III. Continuation of Policy. Except as inconsistent with this
realignment, all statements of policy and interpretations with respect
to organizational components affected by this notice within ACF,
heretofore issued and in effect on this date of this realignment are
continued in full force and effect.
IV. Delegation of Authority. All delegations and redelegations of
authority made to officials and employees of affected organizational
components will continue in them or their successors pending further
redelegations, provided they are consistent with this realignment.
V. Funds, Personnel, and Equipment. Transfer of organizations and
functions affected by this realignment shall be accompanied in each
instance by direct and support funds, positions, personnel, records,
equipment, supplies, and other resources.
This realignment will be effective upon date of signature.
Dated: June 12, 2015.
Mark H. Greenberg,
Acting Assistant Secretary for Children and Families.
[FR Doc. 2015-15237 Filed 6-19-15; 8:45 am]
BILLING CODE 4184-34-P
